特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
927876

ニチノール医療機器市場 - 成長、傾向、予測 (2020 - 2025)

Nitinol Medical Devices Market - Growth, Trends And Forecast (2020 - 2025)

出版日: | 発行: Mordor Intelligence LLP | ページ情報: 英文 117 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.45円
ニチノール医療機器市場 - 成長、傾向、予測 (2020 - 2025)
出版日: 2020年03月01日
発行: Mordor Intelligence LLP
ページ情報: 英文 117 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界のニチノール医療機器市場は、2020年から2025年にかけて9.1%のCAGRで拡大すると予測されています。超弾性で知られるニチノールは、心血管疾患、腎結石症などの疾患の負担が高まりと低侵襲手術の採用の増加により、 市場の成長が促されています。

当レポートでは、ニチノール医療機器の世界市場を調査し、市場の概要、タイプ、用途、地域別の市場動向、市場規模の推移と予測、市場促進・阻害要因ならびに市場機会の分析、競合情勢、主要企業のプロファイルなど包括的な情報を提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場のダイナミクス

  • 市場概要
  • 成長要因
    • 慢性疾患の負担の増大
    • 低侵襲手術の優先順位の上昇
  • 抑制要因
    • 高コストのデバイス
    • 代替デバイスの存在
  • ファイブフォース分析

第5章 市場セグメンテーション

  • 製品タイプ別
    • ステント
    • バスケット
    • ガイドワイヤー
    • その他
  • 用途別
    • 心血管
    • 泌尿器科
    • 歯科
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Arthrex Inc
    • B. Braun Melsungen
    • Boston Scientific Inc
    • Becton, Dickinson & Company
    • Cook Medical
    • EndoSmart GmbH
    • Merck KGaA
    • Terumo IS (Terumo Corporation)
    • WL Gore & Associate Inc.
    • Zimmer Biomet

第7章 市場機会および将来動向

目次
Product Code: 68215

The Nitinol Medical Devices Market is expected to register a CAGR of 9.1% over the forecast period. Growing burden of diseases and increasing adoption of minimally invasive surgeries is expected to propel the global nitinol medical devices market growth. Nitinol known for its super-elasticity, has wide number of applications in the healthcare industry. According to the World Health Organization, cardiovascular disease is the major cause of death worldwide and around 17.9 million people die due to it. With the higher burden of diseases such as cardiovascular disorders, renal lithiasis, etc., the demand for nitinol medical devices is also expected to increase. However, the presence of alternative to these devices may impel the nitinol medical devices market growth.

Key Market Trends

Stents Segment is Expected to Hold a Major Share in the Nitinol medical Devices Market

Stents are tiny tubes that are used for insertion into a blocked passageway. Nitinol stents exhibit some unique properties that makes it more efficient than other stents. These stents are engineered in such a way that when inserted, it adjusts itself into the wall of the vessel and resists it's forces. Also, these stents are less corrosive even though there is a presence of nickel.

According to the American Cancer Society, approximately 18,440 new cases have been diagnosed with esophageal cancer for the year 2020, in the United States. Such factors helps the care providers to use better stents in the market where the nitinol stents are useful and commonly due to its self-expanding characteristic, thereby, expected to drive the stents segment.

Furthermore, adoption of minimally invasive surgeries is expected to influence positively on the nitinol stents segment. For instance, angioplasty is a minimal invasive surgery that requires a balloon tipped catheter to insert into a blocked vessel and a stent to inflate the balloon. According to the study of Eurostat, in 2017, around 1.2 million procedures related to transluminal coronary angioplasty were conducted.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to be a dominant region in nitinol medical devices market growth due to the growing burden of diseases and increase in adoption of minimally invasive procedures. Coronary heart disease also known as ischemic heart disease is caused due to formation of plaque in the wall of arteries. According to the Centre for Disease Control and Prevention, coronary artery disease is one of the most affected heart diseases in the United States. In coronary artery disease, plaque builds up and blocks the arteries as a result there is improper flow of blood. For removal of these blockages generally stents are used. Hence, these factor is expected to impact positively on the nitinol medical devices market growth in this particular region.

Competitive Landscape

The Nitinol medical Devices Market is fragmented and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are EndoSmart GmbH, Boston Scientific Inc., B. Braun Melsungen, Arthrex Inc., Zimmer Biomet, Cook Medical, Terumo IS, Merck KGaA, Becton, Dickinson & Company and W.L. Gore & Associate Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Chronic Diseases
    • 4.2.2 Rising Preference for Minimally Invasive Surgeries
  • 4.3 Market Restraints
    • 4.3.1 High-cost of Devices
    • 4.3.2 Presence of Alternative Devices
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Stents
    • 5.1.2 Baskets
    • 5.1.3 Guidewires
    • 5.1.4 Others
  • 5.2 By Application
    • 5.2.1 Cardiovascular
    • 5.2.2 Urology
    • 5.2.3 Dentistry
    • 5.2.4 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Arthrex Inc
    • 6.1.2 B. Braun Melsungen
    • 6.1.3 Boston Scientific Inc
    • 6.1.4 Becton, Dickinson & Company
    • 6.1.5 Cook Medical
    • 6.1.6 EndoSmart GmbH
    • 6.1.7 Merck KGaA
    • 6.1.8 Terumo IS (Terumo Corporation)
    • 6.1.9 W.L. Gore & Associate Inc.
    • 6.1.10 Zimmer Biomet

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.